• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

drchrono releases API for developers

Article

Drchrono, Inc. recently launched its application programming interface (API) that will allow developers to build their own healthcare applications.

Mountain View, CA-Drchrono, Inc., the creator of a free electronic medical record (EMR) platform on the iPad, iPhone, and cloud, recently released its application programming interface (API)
 that will allow developers to build their own healthcare applications on top of the drchrono platform.

Only 1.3% of APIs listed on ProgrammableWeb, an API database, are associated with the medical services sector. Innovators have avoided developing applications for the healthcare industry due to high regulations and the difficulty in accessing APIs from health institutions. Drchrono wants to ease developers’ requests to the API as easy as a sign-up and one-week review process. Drchrono would like to encourage developers to find opportunities in the evolving healthcare space to launch new companies. The current procedure for accessing a health institution’s API involves working with the organization’s business development team, a potentially lengthy process. Because each institution uses its own API, it can be a very time consuming process for companies to access it. By leveraging drchrono, these organizations can access their patients’ information for application construction within a week. 

Related Videos
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.